Oppenheimer raised the firm’s price target on Camtek (CAMT) to $120 from $105 and keeps an Outperform rating on the shares. The firm notes shares traded down 7% after reporting in-line Q3 results with revenue of $126.0M and non-GAAP EPS of 82c, both 1% above expectations. Guidance for Q4 is flat sequential growth and a back-end-loaded 2026.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAMT:
- Camtek price target raised to $120 from $85 at Barclays
- Camtek’s Strong Growth Prospects and Strategic Positioning Justify Buy Rating and $125 Price Target
- Camtek Reports Record Q3 2025 Financial Results
- Camtek price target raised to $120 from $115 at Stifel
- Camtek’s Strong Growth Prospects and Strategic Expansions Justify Buy Rating